Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Baker Hughes Incorporated (BHI): ValueAct Reports Activist Stake as Company Reports Strong Financial Results

Page 1 of 2

In a new filing with the Securities and Exchange Commission, Jeff Ubben‘s ValueAct Capital reported a new stake in the $25 billion oilfield services company Baker Hughes Incorporated (NYSE:BHI). ValueAct reported holding an activist stake in the company that amasses 21.95 million shares, which represent 5.1% of the outstanding common stock. The investor added in the filing that it may further alter its stake, but also may discuss with the management or directors of Baker Hughes, as well as other interest parties and propose different changes in the company’s operations’ governance or capitalization. So far, however, ValueAct did not specify any plans regarding its involvement in the current operations of Baker Hughes.


Mr. Ubben initiated its stake in the company a couple of days before Baker Hughes Incorporated (NYSE:BHI) reported its financial results for the fourth quarter and full year 2014. For last year, the company’s revenue amounted to $24.6 billion, which represents a 10% increase on the year. In addition its EBITDA and net income (non-GAAP basis), went up by 30% and 59% on the year respectively to $4.8 billion and $4.22 per share respectively. In addition, Baker Hughes beat the analyst consensus estimates, which represented EPS of $4.17 and revenue of $24.5 billion. Moreover, the stock of Baker Hughes outperformed its peers from the Oil & Gas Equipment and Services industry, returning 4.60% over the last 52 weeks, versus the average return for the industry of -12.60%.

Since Baker Hughes Incorporated (NYSE:BHI) reported its results earlier today, analysts haven’t yet presented their opinion regarding the company’s results and future prospects. However, earlier this year, Barclays and KeyCorp initiated coverage on the stock and set ‘Overweight’ and ‘Hold’ ratings. Among other analysts in aggregate, Baker Hughes’ stock has a consesus ‘Buy’ rating and a price target of $76.00, which is a significant premium over the current price of around $56.80.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!